The InjectCo compounded semaglutide program provides everything needed for medically supervised weight loss beyond just the medication
Whilst semaglutide is not extensively metabolised by the liver and appears safe in most hepatic conditions, patients with existing liver disease require individualised assessment and appropriate monitoring
PlexusDx offers Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan with no membership fees or insurance requirements, making continuous therapy more accessible than many assume
Care is delivered through a secure, HIPAA-compliant virtual healthcare model designed for long-term clinical partnership, and may include online health assessments, video consultations when clinically required, lab-informed reviews, metabolic monitoring, individualized treatment plans, and ongoing dose adjustments based on each patients medical history, treatment response, and licensed provider judgment
The Phase 2 trial starting dose was 2 mg once weekly by subcutaneous injection, mirroring the initiation approach used with other incretin-based therapies
Reports to FAERS have not been verified to determine causation but can provide a guide to potential trends deserving of follow-up study by medical authorities
